Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson’s disease models. Neurobiology of Disease; https://doi.org/10.1016/j.nbd.2018.10.016. Weihofen, Liu, Arndt, et al (2017)
Neurobiology of Disease; https://doi.org/10.1016/j.nbd.2018.10.016.
